Gaa na ọdịnaya

Anna-Lise Williamson

Shí Wikipedia, njikotá édémédé nke onyobulạ

 

Anna-Lise Williamson FRSSAf MASSAf bụ onye na-ahụ maka nje virus na South Afrika Prọfekwa ọ nke Virology na Mahadum nke Cape Town . [1] Ebe ọ bụ ọkachamara bụ human papillomavirus, mana a makwaara ya na mba ụwa maka ọrụ ya n'ịmepụta ọgwụ mgbochi ọrịa HIV. E webatara ọgwụ mgbochi ndị a na nzọụkwụ 1 nke nnwale ahụike. Williamson ebipụtala ihe karịrị akwụkwọ 120. [2]

ebipụtaraMmụta

[dezie | dezie ebe o si]

Williamson nwetara PhD na Mahadum nke Witwatersrand na afọ 1985. Akwụkwọ edemede Ph.D. ya bụ "Ọmụmụ ihe gbasara microscopic na immunocytochemical nke ElectronJaagsiekte". [3] Williamson bụkwa onye otu na Royal Society nke South frika adum Cape Town . [2][3]

Ihe ndị ọ rụzuru

[dezie | dezie ebe o si]

Anna-Lise Williamson bụkwa onye nduzi nke Mahadum nke otu nyocha ọgwụ mgbochi nke Cape Town GLP. Ebe ọ bụ ọkachamara na ihe a maara nke ọma bụ Human Papillomavirus Nje HIV Vaccines . [1]

  • E nyere ya oche na Vaccinology 2008 (South African Research Chairs Initiative)
  • Onye isi nke World Health Organization human papillomavirus Labnet lab maka mpaghara Africa
  • Onye isi nke Mahadum Cape Town, National Institute for communicable Diseases, na National Health Laboratory Service Molecular Epidemiology Laboratory
  • Onye otu South African HPV Advisory Board [2]
  • Onye otu Academy of Science nke South Africa [4]

Onyinye

[dezie | dezie ebe o si]

Anna-Lise Williamson bụrụ onye isi nke mmepe ọgwụ mgbochi HIV na otu nyocha nke papilloma mmadụ na Mahadum Cape Town. Na ebe ahụ, Williamson na otu ndị karịrị mmadụ 30 na-emepụta ọgwụ mgbochi maka nje HIV-1 subtype C. A maara ụdị a dị ka nke kachasị njọ, ma mara na ọ bụ ụdị isi nke na-eduga na ọrịa AIDS.[5] Ebumnuche nke nyocha ahụ bụ ịmepụta ọgwụ mgbochi HIV-1 C dị ọnụ ala ma dị irè, [2] nke ga-eme ka ogologo ndụ nke mkpụrụ ndụ T dịkwuo ma mepụta ojiji na-arụ ọrụ nke CD4 + na CD8 + mmeghachi omume mkpụrụ ndụ.[6][7][8] A họrọla ọgwụ mgbochi abụọ iji gaa n'ihu na nnwale ahụike. Ọgwụ mgbochi ndị a bụ ọgwụ mgbochi DNA na ọgwụ mgbochi ọrịa nje nke Ankara. E mepụtara ọgwụ mgbochi ahụ dị ka akụkụ nke Mbuli Ọgwụ Mgbochi Ọrịa AIDS nke South Afrika (SAAVI). [2][5]

Akwụkwọ ndị a họọrọ

[dezie | dezie ebe o si]

Anna-Lise Williamson ebipụtara ihe karịrị akwụkwọ 120. Akwụkwọ ya na-agụnye ngalaba nka ya na-ekwu maka mmepe ọgwụ mgbochi HIV, nje HIV, na nje HPV.

  • Marais (2007). "Cervical Human Papillomavirus (HPV) Infection and HPV Type 16 Antibodies in South African Women". Journal of Clinical Microbiology 46 (2): 732–739. DOI:10.1128/JCM.01322-07. ISSN 0095-1137. PMID 18077644. Ebumnuche nke mbipụta a bụ ịchọpụta ụdị HIV-1 na ụmụ nwoke na-edina nwoke na ụmụ nwoke ma na-edine nwoke na Cape Town, South Africa.[9]
  • Shephard (2008). "A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice". AIDS Research and Human Retroviruses 24 (2): 207–217. DOI:10.1089/aid.2007.0206. ISSN 0889-2229. PMID 18240963. Ebumnuche nke mbipụta a bụ ịchọpụta mmụba na ihe ize ndụ metụtara ọrịa HPV, na HPV-16 antibody na ndị bi na Southern Africa.
  • Adler (2008). "Human Papillomavirus Genotype Distribution among Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Women in Soweto, South Africa". Journal of Clinical Microbiology 46 (12): 4109–4110. DOI:10.1128/JCM.01667-08. ISSN 0095-1137. PMID 18945842. 
  • Burgers (2009). "Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons". Journal of General Virology 90 (2): 468–480. DOI:10.1099/vir.0.004614-0. ISSN 0022-1317. PMID 19141458. 
  • Marais (2009). "HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers". Journal of Medical Virology 81 (2): 203–210. DOI:10.1002/jmv.21343. ISSN 0146-6615. PMID 19107974. [1]

Edemsibia

[dezie | dezie ebe o si]
  1. ↑ 1.0 1.1 1.2 Williamson, Anna-Lise. The Division of Medical Virology, UCT.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Williamson, Anna-Lise. HIV Vaccine development group and Human papilloma virus research group. Archived from the original on 18 May 2015. Retrieved on 6 December 2025.
  3. ↑ Fellows (FRSSAf) (4 April 2013).
  4. ↑ Members.
  5. ↑ 5.0 5.1 HIV Vaccine info-line 080 Vaccine.
  6. ↑ (2000) "The development of HIV-1 subtype vaccines of SOuthern Africa". IUBMB Life 53 (4–5): 207–208. DOI:10.1080/15216540212648. PMID 12120996. 
  7. ↑ (2000) "Designing HIV-1 subtype C vaccines for South Africa". South African Journal of Science 96 (6): 318–323. 
  8. ↑ (Feb 2004) "Human Immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to subtype C gag DNA vaccine in mice". Journal of General Virology 85 (2): 409–413. DOI:10.1099/vir.0.19396-0. PMID 14769898. 
  9. ↑ (11 Jan 2007) "An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa". AIDS 11 (1): 81–87. DOI:10.1097/00002030-199701000-00012. PMID 9110079. 

Ebe e si nweta ya

[dezie | dezie ebe o si]

 

Njikọ mpụga

[dezie | dezie ebe o si]

 

Ewepụtara site na "https://ig.wikipedia.org/w/index.php?title=Anna-Lise_Williamson&oldid=541409"